Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Chronic obstructive pulmonary disease ( COPD ) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs.
The report details the trend, potential and market size of Chronic Obstructive Pulmonary Disease Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Chronic Obstructive Pulmonary Disease Drugsmarket, defines the market attractiveness level of Chronic Obstructive Pulmonary Disease Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Chronic Obstructive Pulmonary Disease Drugs industry, describes the types of Chronic Obstructive Pulmonary Disease Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chronic Obstructive Pulmonary Disease Drugs market and the development prospects and opportunities of Chronic Obstructive Pulmonary Disease Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chronic Obstructive Pulmonary Disease Drugs market in Chapter 13.
By Player:
Ario Pharma
Novartis
Asmacure
GSK
Aquinox Pharmaceuticals
AstraZeneca
Ache Laboratorios Farmaceuticos
BioMarck Pharmaceuticals
Almirall
Teva Pharmaceuticals
Boehringer Ingelheim
Astellas Pharma
By Type:
Inhalers
Nebulizers
By End-User:
Emphysema
Chronic Bronchitis
Refractory Asthma
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Chronic Obstructive Pulmonary Disease Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Chronic Obstructive Pulmonary Disease Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Chronic Obstructive Pulmonary Disease Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Chronic Obstructive Pulmonary Disease Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Chronic Obstructive Pulmonary Disease Drugs Market Analysis and Outlook to 2022
-
7.1 Global Chronic Obstructive Pulmonary Disease Drugs Consumption (2017-2022)
-
7.2 United States Chronic Obstructive Pulmonary Disease Drugs Consumption (2017-2022)
-
7.3 Europe Chronic Obstructive Pulmonary Disease Drugs Consumption (2017-2022)
-
7.4 China Chronic Obstructive Pulmonary Disease Drugs Consumption (2017-2022)
-
7.5 Japan Chronic Obstructive Pulmonary Disease Drugs Consumption (2017-2022)
-
7.6 India Chronic Obstructive Pulmonary Disease Drugs Consumption (2017-2022)
-
7.7 South Korea Chronic Obstructive Pulmonary Disease Drugs Consumption (2017-2022)
8 Region and Country-wise Chronic Obstructive Pulmonary Disease Drugs Market Analysis and Outlook to 2028
-
8.1 Global Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2022-2028)
-
8.2 United States Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2022-2028)
-
8.4 China Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2022-2028)
-
8.6 India Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast (2022-2028)
9 Global Chronic Obstructive Pulmonary Disease Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Chronic Obstructive Pulmonary Disease Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Inhalers Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Nebulizers Consumption and Growth Rate (2017-2022)
-
9.2 Global Chronic Obstructive Pulmonary Disease Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Emphysema Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Chronic Bronchitis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Refractory Asthma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Chronic Obstructive Pulmonary Disease Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Inhalers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Nebulizers Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Emphysema Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Chronic Bronchitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Refractory Asthma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Chronic Obstructive Pulmonary Disease Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Chronic Obstructive Pulmonary Disease Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Chronic Obstructive Pulmonary Disease Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Chronic Obstructive Pulmonary Disease Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Chronic Obstructive Pulmonary Disease Drugs Market Competitive Analysis
-
14.1 Ario Pharma
-
14.1.1 Ario Pharma Company Details
-
14.1.2 Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
14.3 Asmacure
-
14.3.1 Asmacure Company Details
-
14.3.2 Asmacure Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Asmacure Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
14.4 GSK
-
14.4.1 GSK Company Details
-
14.4.2 GSK Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GSK Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
14.5 Aquinox Pharmaceuticals
-
14.5.1 Aquinox Pharmaceuticals Company Details
-
14.5.2 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
14.6 AstraZeneca
-
14.6.1 AstraZeneca Company Details
-
14.6.2 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
14.7 Ache Laboratorios Farmaceuticos
-
14.7.1 Ache Laboratorios Farmaceuticos Company Details
-
14.7.2 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
14.8 BioMarck Pharmaceuticals
-
14.8.1 BioMarck Pharmaceuticals Company Details
-
14.8.2 BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
14.9 Almirall
-
14.9.1 Almirall Company Details
-
14.9.2 Almirall Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Almirall Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
14.10 Teva Pharmaceuticals
-
14.10.1 Teva Pharmaceuticals Company Details
-
14.10.2 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
14.11 Boehringer Ingelheim
-
14.11.1 Boehringer Ingelheim Company Details
-
14.11.2 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
14.12 Astellas Pharma
-
14.12.1 Astellas Pharma Company Details
-
14.12.2 Astellas Pharma Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Astellas Pharma Chronic Obstructive Pulmonary Disease Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Chronic Obstructive Pulmonary Disease Drugs
-
Figure Chronic Obstructive Pulmonary Disease Drugs Picture
-
Table Global Chronic Obstructive Pulmonary Disease Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Chronic Obstructive Pulmonary Disease Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Chronic Obstructive Pulmonary Disease Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Chronic Obstructive Pulmonary Disease Drugs Consumption by Country (2017-2022)
-
Figure United States Chronic Obstructive Pulmonary Disease Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Chronic Obstructive Pulmonary Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Chronic Obstructive Pulmonary Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Chronic Obstructive Pulmonary Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Chronic Obstructive Pulmonary Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Chronic Obstructive Pulmonary Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Chronic Obstructive Pulmonary Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inhalers Consumption and Growth Rate (2017-2022)
-
Figure Global Nebulizers Consumption and Growth Rate (2017-2022)
-
Figure Global Emphysema Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Bronchitis Consumption and Growth Rate (2017-2022)
-
Figure Global Refractory Asthma Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Inhalers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nebulizers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Emphysema Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Bronchitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Refractory Asthma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Chronic Obstructive Pulmonary Disease Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Chronic Obstructive Pulmonary Disease Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Ario Pharma (Foundation Year, Company Profile and etc.)
-
Table Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ario Pharma Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
Table Asmacure (Foundation Year, Company Profile and etc.)
-
Table Asmacure Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Asmacure Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
Table Aquinox Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
Table Ache Laboratorios Farmaceuticos (Foundation Year, Company Profile and etc.)
-
Table Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
Table BioMarck Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
Table Almirall (Foundation Year, Company Profile and etc.)
-
Table Almirall Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Almirall Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
Table Teva Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceuticals Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Chronic Obstructive Pulmonary Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Chronic Obstructive Pulmonary Disease Drugs Product and Service
-
